[A "good death" needs to be discussed. A study of patients with acute myeloid leukemia demonstrates the value of palliative care].

The incidence of AML in Sweden is 5.4/100,000, i.e.

The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain.

To increase the knowledge of the final phase of acute myeloid leukaemia (AML) a retrospective review of the medical and nursing records of 106 adult patients with AML who had died in 1995-1997 was made. A total of 27 patients were treated with curative intent at the time of death and 79 patients were prescribed palliative care. From the documentation, an evaluation of the frequency and severity of bleeding and pain episodes was made during their last week in life, and the occurrence of infection criteria was studied.